Profitability
Weight: 25%
C+
59
- 5yr Avg ROIC 7.4%
- Operating Margin Trend +1.15 pp/yr
BMY
Bristol-Myers Squibb Company
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
A
92
- 5yr Avg ROE 21.1%
- 5yr Share-Count CAGR -2.4%
Growth Quality
Weight: 25%
D
34
- 5yr Revenue CAGR 1.0%
- 5yr EPS CAGR 2.5%
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 20%
A
92
- 5yr FCF Margin 28.5%
- 5yr FCF/NI Conversion 1.87x
Balance Sheet
Weight: 10%
B-
62
- Net Debt / EBITDA 2.51x
- Interest Coverage (EBIT/Int) 7.08x
- Altman Z-Score 2.41
Stability
Weight: 5%
C
54
- EPS Volatility (σ/μ) 0.44
- Piotroski F-Score 8
- Negative-Revenue Years (5) 3/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 4 gurus held; 2 added; 2 trimmed.
- Holders
- 4
- Avg Δ position
- +175.0%
- New buys
- 0
- Full exits
- 0